Condition category
Not Applicable
Date applied
29/09/2006
Date assigned
29/09/2006
Last edited
08/09/2015
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Dr Emma McCann

ORCID ID

Contact details

c/o Royal Liverpool Children's Hospital
Eaton Road
Liverpool
L12 2AP
United Kingdom

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

N0128162659

Study information

Scientific title

The introduction and evaluation of patient-clinician email communication in Merseyside clinical genetics service

Acronym

Study hypothesis

Does email communication have a role in the patient-clinician relationship in clinical genetics? Would patients, who present to the clinical genetics team, use email to communicate with the department?

Ethics approval

Not provided at time of registration

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Not specified

Trial type

Other

Patient information sheet

Not available in web format, please use the contact details below to request a patient information sheet

Condition

Email communication in patient-clinician relationship

Intervention

Randomised controlled trial. Intervention group: email address and telephone number. Control group: telephone number only.

Patients will be identified and invited to take part in the study at two separate points in the referral pathway:
1. At the home visit by a genetic counsellor.
2. At the clinic visit by a clinical geneticist and/or Dr Emma McCann.

Intervention type

Other

Phase

Not Specified

Drug names

Primary outcome measures

Comparison of "email and telephone" group with "telephone" group only. Is there a difference in the proportions contacting the department? Assess number of contacts per person.

Secondary outcome measures

Not provided at time of registration

Overall trial start date

20/04/2005

Overall trial end date

20/10/2006

Reason abandoned

Eligibility

Participant inclusion criteria

1. Referral to clinical genetics
2. Over 16 years of age or the parent/guardian of children under 16 years of age
3. With access to email

Participant type

Patient

Age group

Adult

Gender

Both

Target number of participants

120 participants in total (60 per arm)

Participant exclusion criteria

Patients attending for prenatal counselling or predictive testing.

Recruitment start date

20/04/2005

Recruitment end date

20/10/2006

Locations

Countries of recruitment

United Kingdom

Trial participating centre

c/o Royal Liverpool Children's Hospital
Liverpool
L12 2AP
United Kingdom

Sponsor information

Organisation

Record Provided by the NHSTCT Register - 2006 Update - Department of Health

Sponsor details

The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
+44 (0)20 7307 2622
dhmail@doh.gsi.org.uk

Sponsor type

Government

Website

http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Hospital/treatment centre

Funder name

Liverpool Women's Hospital NHS Trust (UK)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Funder name

NHS R&D Support Funding (UK)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

Publication citations

Additional files

Editorial Notes